- Fragile X
- Treatment & Intervention
- Support the NFXF
Kennedy Krieger Institute is looking for children, ages 5 through 13 years, with Fragile X syndrome to participate in a research study.
The purpose of this study is to determine if an investigational drug is a safe and effective treatment for symptoms associated with Fragile X syndrome.
Participation in this study will require up to 9 visits (each lasting 2-10 hours) to the Kennedy Krieger Institute in Baltimore, MD and up to 10 between-visit phone calls with the study doctor over an 18-week period.
Eligible participants may receive reimbursement for time and travel. The investigational drug and all study-related evaluations are provided at no cost to the participants.
Contact the Study Coordinator
(443) 923-7619 or ResearchTrials@kennedykrieger.org
Michael Johnston MD, Principal Investigator
NA_00079628 www.clinicaltrials.gov (#)
Project sponsors: Hoffmann-La Roche Inc.
Approved Mar 27, 2013